FDA Approves Drug That Costs a Whopping $700,000 a Year
2017-04-28
0
The FDA has approved the first medicinal treatment for a form of Batten disease called CLN2 disease.
Please enable JavaScript to view the
comments powered by Disqus.
Videos similaires
FDA approves first-ever generic version of insulin, which will dramatically cut costs
FDA approves Celltrion’s biosimilar drug Remsima for sales in U.S.
FDA approves Litfulo, alopecia areata hair loss drug for teens 12+ - 1breakingnews.com
US: FDA approves first cancer drug based on genetics of patient
FDA approves first COVID-19 drug - antiviral remdesivir, and other top stories in business from October 23, 2020.
Breakthrough or risk FDA approves Alzheimer's drug
FDA Approves Asthma Drug to Mitigate Fatal Food Allergy Reactions
FDA approves first postpartum depression drug, Zurzuvae - 1breakingnews.com
FDA approves new Alzheimer’s drug from Eli Lilly
FDA approves drug to delay onset of Type 1 diabetes - 1breakingnews.com